Stratification of Liver Stiffness according to eGFR in the MAFLD group.
<p>Stratification of Liver Stiffness according to eGFR in the MAFLD group.</p>
Đã lưu trong:
| Tác giả chính: | |
|---|---|
| Tác giả khác: | , , , , , |
| Được phát hành: |
2025
|
| Những chủ đề: | |
| Các nhãn: |
Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
| _version_ | 1849927642881458176 |
|---|---|
| author | Zienab M. Saad (22676502) |
| author2 | Hesham K. H. Keryakos (22676505) Hala A. Hassanin (22676508) Mahmoud M. Higazi (22676511) Manar M. Sayed (22676514) Doaa E. Ismail (22676517) Safaa M. Abdelhalim (21398199) |
| author2_role | author author author author author author |
| author_facet | Zienab M. Saad (22676502) Hesham K. H. Keryakos (22676505) Hala A. Hassanin (22676508) Mahmoud M. Higazi (22676511) Manar M. Sayed (22676514) Doaa E. Ismail (22676517) Safaa M. Abdelhalim (21398199) |
| author_role | author |
| dc.creator.none.fl_str_mv | Zienab M. Saad (22676502) Hesham K. H. Keryakos (22676505) Hala A. Hassanin (22676508) Mahmoud M. Higazi (22676511) Manar M. Sayed (22676514) Doaa E. Ismail (22676517) Safaa M. Abdelhalim (21398199) |
| dc.date.none.fl_str_mv | 2025-11-24T18:27:12Z |
| dc.identifier.none.fl_str_mv | 10.1371/journal.pone.0336568.g004 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Stratification_of_Liver_Stiffness_according_to_eGFR_in_the_MAFLD_group_/30696942 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Medicine Cell Biology Biotechnology Marine Biology Cancer Infectious Diseases Virology shear wave elastography patients remains underexplored mitigate progression risks higher liver stiffness 56 ± 17 43 ± 17 5 ± 28 ></ b >). ></ b >), ></ b >) shared metabolic abnormalities 9 ± 39 invasive fibrosis scores 45 ± 1 2 ± 5 mafld patients also dialysis ckd patients 108 ckd patients metabolic risk factors 5 ± 6 9 ± 1 5 ± 3 6 ± 1 xlink "> mafld xlink "> 5 %, b >< metabolic dysfunction 9 ml risk populations fibrosis severity advanced fibrosis 1 years 2 vs ckd severity 1 vs 6 vs study aimed sectional study participants stratified older age nafld score management strategies lower egfr integrated screening insulin resistance findings highlight diagnostic criteria bidirectional relationship apri score |
| dc.title.none.fl_str_mv | Stratification of Liver Stiffness according to eGFR in the MAFLD group. |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Stratification of Liver Stiffness according to eGFR in the MAFLD group.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_a1f39944991c6c9e35eef01417712742 |
| identifier_str_mv | 10.1371/journal.pone.0336568.g004 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30696942 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Stratification of Liver Stiffness according to eGFR in the MAFLD group.Zienab M. Saad (22676502)Hesham K. H. Keryakos (22676505)Hala A. Hassanin (22676508)Mahmoud M. Higazi (22676511)Manar M. Sayed (22676514)Doaa E. Ismail (22676517)Safaa M. Abdelhalim (21398199)MedicineCell BiologyBiotechnologyMarine BiologyCancerInfectious DiseasesVirologyshear wave elastographypatients remains underexploredmitigate progression riskshigher liver stiffness56 ± 1743 ± 175 ± 28></ b >).></ b >),></ b >)shared metabolic abnormalities9 ± 39invasive fibrosis scores45 ± 12 ± 5mafld patients alsodialysis ckd patients108 ckd patientsmetabolic risk factors5 ± 69 ± 15 ± 36 ± 1xlink "> mafldxlink ">5 %,b ><metabolic dysfunction9 mlrisk populationsfibrosis severityadvanced fibrosis1 years2 vsckd severity1 vs6 vsstudy aimedsectional studyparticipants stratifiedolder agenafld scoremanagement strategieslower egfrintegrated screeninginsulin resistancefindings highlightdiagnostic criteriabidirectional relationshipapri score<p>Stratification of Liver Stiffness according to eGFR in the MAFLD group.</p>2025-11-24T18:27:12ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1371/journal.pone.0336568.g004https://figshare.com/articles/figure/Stratification_of_Liver_Stiffness_according_to_eGFR_in_the_MAFLD_group_/30696942CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/306969422025-11-24T18:27:12Z |
| spellingShingle | Stratification of Liver Stiffness according to eGFR in the MAFLD group. Zienab M. Saad (22676502) Medicine Cell Biology Biotechnology Marine Biology Cancer Infectious Diseases Virology shear wave elastography patients remains underexplored mitigate progression risks higher liver stiffness 56 ± 17 43 ± 17 5 ± 28 ></ b >). ></ b >), ></ b >) shared metabolic abnormalities 9 ± 39 invasive fibrosis scores 45 ± 1 2 ± 5 mafld patients also dialysis ckd patients 108 ckd patients metabolic risk factors 5 ± 6 9 ± 1 5 ± 3 6 ± 1 xlink "> mafld xlink "> 5 %, b >< metabolic dysfunction 9 ml risk populations fibrosis severity advanced fibrosis 1 years 2 vs ckd severity 1 vs 6 vs study aimed sectional study participants stratified older age nafld score management strategies lower egfr integrated screening insulin resistance findings highlight diagnostic criteria bidirectional relationship apri score |
| status_str | publishedVersion |
| title | Stratification of Liver Stiffness according to eGFR in the MAFLD group. |
| title_full | Stratification of Liver Stiffness according to eGFR in the MAFLD group. |
| title_fullStr | Stratification of Liver Stiffness according to eGFR in the MAFLD group. |
| title_full_unstemmed | Stratification of Liver Stiffness according to eGFR in the MAFLD group. |
| title_short | Stratification of Liver Stiffness according to eGFR in the MAFLD group. |
| title_sort | Stratification of Liver Stiffness according to eGFR in the MAFLD group. |
| topic | Medicine Cell Biology Biotechnology Marine Biology Cancer Infectious Diseases Virology shear wave elastography patients remains underexplored mitigate progression risks higher liver stiffness 56 ± 17 43 ± 17 5 ± 28 ></ b >). ></ b >), ></ b >) shared metabolic abnormalities 9 ± 39 invasive fibrosis scores 45 ± 1 2 ± 5 mafld patients also dialysis ckd patients 108 ckd patients metabolic risk factors 5 ± 6 9 ± 1 5 ± 3 6 ± 1 xlink "> mafld xlink "> 5 %, b >< metabolic dysfunction 9 ml risk populations fibrosis severity advanced fibrosis 1 years 2 vs ckd severity 1 vs 6 vs study aimed sectional study participants stratified older age nafld score management strategies lower egfr integrated screening insulin resistance findings highlight diagnostic criteria bidirectional relationship apri score |